TickerFactsScreenerDevelopers

TScan Therapeutics, Inc. (TCRX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$3.02M2021: -$48.68M2022: -$66.50M2023: -$61.36M2024: -$110.82M2025: -$135.32M-$135.32M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$135.32M-22.1%
2024-$110.82M-80.6%
2023-$61.36M+7.7%
2022-$66.50M-36.6%
2021-$48.68M-1510.2%
2020-$3.02M—